We found that 75% of patients with HR cytogenetics (6/8) were in the >3 FLs group but this did not reach statistical significance ( p = 0.24).
← all excerpts
Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy.
1
0.2400
0.2400